ResearcherSichuan UniversityNo recent work listed

Xianzhou Huang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5112388784. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 2 papers

Papers 2

A self-sustained nanoplatform reverses TRAIL-resistance of pancreatic cancer through coactivating of exogenous and endogenous apoptotic pathway. Co-author DOI 10.1016/j.biomaterials.2021.120795 ↗
Recombinant protein TRAIL-Mu3 enhances the antitumor effects in pancreatic cancer cells by strengthening the apoptotic signaling pathway. Co-author DOI 10.3892/ol.2021.12699 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Ying Huang · 1 shared paper, 2021 · strength 0.14
- Paper Recombinant protein TRAIL-Mu3 enhances the antitumor effects in pancreatic cancer cells by strengthening the apoptotic … DOI 10.3892/ol.2021.12699 ↗
Min Huang · 1 shared paper, 2021 · strength 0.14
- Paper Recombinant protein TRAIL-Mu3 enhances the antitumor effects in pancreatic cancer cells by strengthening the apoptotic … DOI 10.3892/ol.2021.12699 ↗
Changyang Gong · 1 shared paper, 2021 · strength 0.13
- Paper A self-sustained nanoplatform reverses TRAIL-resistance of pancreatic cancer through coactivating of exogenous and endo… DOI 10.1016/j.biomaterials.2021.120795 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.